BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,413,000 | -67.6% | 82,110 | -68.8% | 0.72% | -61.1% |
| Q2 2022 | $38,326,000 | +16.7% | 263,030 | -5.0% | 1.85% | +41.6% |
| Q1 2022 | $32,845,000 | -15.5% | 277,006 | -1.8% | 1.31% | -5.1% |
| Q4 2021 | $38,856,000 | -1.4% | 281,951 | -0.6% | 1.38% | -5.3% |
| Q3 2021 | $39,416,000 | +39.6% | 283,750 | -2.4% | 1.46% | +45.1% |
| Q2 2021 | $28,237,000 | +56.2% | 290,861 | +9.9% | 1.00% | +70.5% |
| Q1 2021 | $18,083,000 | – | 264,558 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |